Key result
Oral paracetamol shows no difference versus oral ibuprofen for PDA closure but reduces closure time.
Why the study?
Available evidence comparing oral paracetamol versus oral ibuprofen for the closure of patent ductus arteriosus in preterm infants needed review.
Does oral paracetamol improve the primary closure rate of patent ductus arteriosus compared to oral ibuprofen in preterm infants?
Meta-Analysis (n=240)
Does oral paracetamol improve the primary closure rate of patent ductus arteriosus compared to oral ibuprofen in preterm infants?
Current evidence is of low quality and insufficient to definitively recommend oral paracetamol over oral ibuprofen for PDA closure in preterm infants, though paracetamol may offer faster closure and a better safety profile.
Answers are grounded in this paper and cite their sources.
Paracetamol offers no primary PDA closure advantage over ibuprofen in preterm infants; low-quality meta-analysis leaves open faster closure as hypothesis-generating.
Objectives: The objective was to review the available evidence comparing oral paracetamol versus oral ibuprofen for the closure of patent ductus arteriosus (PDA) in preterm infants. Methods: We searched all the major databases (Medline via Ovid and PubMed) till April 2014. Randomized trials were included. Primary outcome measure was the primary closure rate of PDA after the first course of the drug. Review manager (version 5.2) was used for all the analyses. GRADE criteria were used to rate the quality of evidence. Results: Of 38 full-text articles assessed for eligibility, two trials ( n = 240) were included in the final analysis. There was no significant difference between the two groups except for the following parameters, which favored the paracetamol group: Shorter mean days needed for PDA closure (mean difference, −0.49 [95% confidence interval [CI], −0.54 to − 0.44], P < 0.00001), a lower risk of gastro-intestinal bleeding (odds ratio [OR], 0.25 [95% CI, 0.06-1.02], P = 0.05) as well as hyperbilirubinemia (OR, 0.46 (95% CI, 0.23-0.95), P = 0.04). The GRADE evidence was found to be of “low quality.” Conclusions: There is not enough evidence to judge about the efficacy or safety of ibuprofen versus paracetamol for treating the PDA in preterm infants. Randomized trials with low risk of bias and adequate sample size including different subgroups of preterm infants are needed before any firm recommendation can be made.
No takes yet. Share an insight, caveat, or question.
Das et al. (2014) conducted a meta-analysis in Patent ductus arteriosus in preterm infants (n=240). Oral paracetamol vs. Oral ibuprofen was evaluated on Primary closure rate of PDA after the first course of the drug. Oral paracetamol showed no significant difference compared to oral ibuprofen for primary PDA closure in preterm infants, but reduced the mean days needed for closure.
Synapse has enriched 10 related papers. Consider them for comparative context: